首页> 外文期刊>Chest >Misclassification of Pulmonary Hypertension Due to Reliance on Pulmonary Capillary Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure
【24h】

Misclassification of Pulmonary Hypertension Due to Reliance on Pulmonary Capillary Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure

机译:由于依赖肺毛细血管楔压而不是左心室舒张末期压强导致的肺动脉高压分类错误

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Pulmonary arterial hypertension (PAH) is typically distinguished from pulmonarynvenous hypertension (PVH) by documenting a pulmonary capillary wedge pressure (PCWP) < 15nmm Hg. However, PCWP has uncertain utility in establishing PAH. We sought to determine thencalibration, discrimination, and diagnostic accuracy of PCWP, using simultaneously measured leftnventricular end-diastolic pressure (LVEDP) as the “gold standard.”nMethods: We examined hemodynamic data from the 11,523 unique patients undergoing simul-ntaneous right-heart and left-heart catheterization at a large academic center from 1998 to 2007.nResults: Among 4,320 patients (37.5%) with pulmonary hypertension (PH) [mean pulmonarynartery pressure, > 25 mm Hg], hemodynamic data were complete for 3,926 patients (90.9%). Ofnthese, 580 patients (14.8%) met the criteria for PAH with a PCWP < 15 mm Hg, but 310 of thesenpatients (53.5%) had an LVEDP > 15 mm Hg. Such discrepancies remained common amongnpatients with a pulmonary vascular resistance > 3 Wood units and those being catheterizednspecifically to evaluate PH. PCWP provided moderate discrimination between patients with highnvs normal LVEDP (area under the receiver operating characteristic curve, 0.84; 95% confidenceninterval, 0.81 to 0.86) but was poorly calibrated to LVEDP (Bland-Altman limits of agreement,nu0001 15.2 to 9.5 mm Hg; Hosmer-Lemeshow goodness-of-fit u00022nstatistic, 155.4; p < 0.0001).nConclusions: Roughly half of the patients presumed to have PAH based on PCWP may be foundnto have PVH based on LVEDP. Reliance on PCWP may result in the dangerous or cost-ineffectivenuse of pulmonary vasodilators for patients with left-heart disease. Furthermore, without assessingnLVEDP, investigators may include patients with left-heart disease in therapeutic trials of PAHndrugs, thereby limiting their ability to detect beneficial drug effects.
机译:背景:肺动脉高压(PAH)与肺静脉高压(​​PVH)的区别通常在于记录的肺毛细血管楔压(PCWP)<15nmm Hg。但是,PCWP在建立PAH方面具有不确定的实用性。我们试图通过同时测量左心室舒张末期压力(LVEDP)作为“黄金标准”来确定PCWP的校准,辨别力和诊断准确性。n方法:我们检查了来自11523名同时进行右心同步手术的独特患者的血流动力学数据结果:1998年至2007年,在大型学术中心进行左心导管检查。n结果:在4,320例肺动脉高压(PH)[平均肺动脉压,> 25 mm Hg]的患者中(37.5%),完成了3,926例患者的血流动力学数据(90.9) %)。其中,有580名患者(14.8%)符合PAH的标准,PCWP <15 mm Hg,但是310名老年患者(53.5%)的LVEDP> 15 mm Hg。这种差异在肺血管阻力> 3 Wood单位的患者和专门用于评估PH的导管患者中仍然很常见。 PCWP可对高nvs正常LVEDP患者(接受者操作特征曲线下的面积,0.84; 95%置信区间,0.81至0.86)进行中等区分,但对LVEDP的校准较差(Bland-Altman协议限值,nu0001为15.2至9.5 mm Hg; Hosmer-Lemeshow拟合优度u00022n统计量,155.4; p <0.0001)。n结论:大约一半的假定基于PCWP的PAH患者可能被发现患有基于LVEDP的PVH。依赖PCWP可能导致左心疾病患者使用肺血管扩张剂危险或成本低效。此外,在不评估nLVEDP的情况下,研究者可能将左心病患者纳入PAHndrugs的治疗试验中,从而限制了他们检测有益药物作用的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号